RBC Maintains Outperform for Acadia Healthcare (ACHC) March 2026

RBC Capital maintained Acadia Healthcare Company, Inc. (ACHC) at Outperform on March 2, 2026, marking the primary change in the latest ACHC analyst rating cycle. The firm also flagged a higher price target in its note, while shares reacted with a 2.39% rise, or $0.55, intraday. This update keeps RBC aligned with a constructive view on Acadia’s operational recovery and leadership shift. The ACHC analyst rating remains a near-term indicator for investors watching post-earnings momentum and strategic execution.